Imbalances in p97 co-factor interactions in human proteinopathy

EMBO Reports

Volumn 11, Issue 6, 2010, Pages 479-485

  Fernández Sáiz, Vanesa ^a,c   Buchberger, Alexander ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ataxin 3; Cdc48; Disease; UFD2a; VCP

Indexed keywords

ATAXIN 3; MUTANT PROTEIN; PROTEIN P97; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E4B; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL STRAIN HEK293; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN CELL; METABOLIC DISORDER; PAGET BONE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEINOPATHY; SPINOCEREBELLAR DEGENERATION;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; FRONTOTEMPORAL DEMENTIA; HUMANS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; MYOSITIS, INCLUSION BODY; NUCLEAR PROTEINS; OSTEITIS DEFORMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EUKARYOTA;

EID: 77953121380     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2010.49     Document Type: Article

References (30)

1. Alexandru G, Graumann J, Smith GT, Kolawa NJ, Fang R, Deshaies RJ (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1a turnover. Cell 134: 804-816
2. Beuron F et al (2006) Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J 25: 1967-1976
3. Boeddrich A et al (2006) An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J 25: 1547-1558
4. DeLaBarre B, Brunger AT (2005) Nucleotide dependent motion and mechanism of action of p97/VCP. J Mol Biol 347: 437-452
5. Duennwald ML, Lindquist S (2008) Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev 22: 3308-3319
6. Halawani D, Leblanc A, Rouiller I, Michnick SW, Servant MJ, Latterich M (2009) Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2-domain and the D1 ring modulate p97/VCP ATPase activity and D2 AAA+ ring conformation. Mol Cell Biol 29: 4484-4494
7. Hirabayashi M et al (2001) VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 8: 977-984
8. Hubbers CU et al (2007) Pathological consequences of VCP mutations on human striated muscle. Brain 130: 381-393
9. Ishigaki S, Hishikawa N, Niwa J, Iemura S, Natsume T, Hori S, Kakizuka A, Tanaka K, Sobue G (2004) Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 279: 51376-51385
10. Janiesch PC, Kim J, Mouysset J, Barikbin R, Lochmuller H, Cassata G, Krause S, Hoppe T (2007) The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat Cell Biol 9: 379-390
11. Ju JS, Miller SE, Hanson PI, Weihl CC (2008) Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem 283: 30289-30299
12. Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187: 875-888
13. Kern M, Fernandez-Saiz V, Schafer Z, Buchberger A (2009) UBXD1 binds p97 through two independent binding sites. Biochem Biophys Res Commun 380: 303-307
14. Kimonis VE, Fulchiero E, Vesa J, Watts G (2008) VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 1782: 744-748
15. Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S, Kakizuka A, Kitagawa M, Nakayama KI (2004) Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J 23: 659-669
16. Meyer HH, Popp O (2008) Role(s) of Cdc48/p97 in mitosis. Biochem Soc Trans 36: 126-130
17. Meyer HH, Shorter JG, Seemann J, Pappin D, Warren G (2000) A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J 19: 2181-2192
18. Mizuno Y, Hori S, Kakizuka A, Okamoto K (2003) Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett 343: 77-80
19. Morreale G, Conforti L, Coadwell J, Wilbrey AL, Coleman MP (2009) Evolutionary divergence of valosin-containing protein/cell division cycle protein 48 binding interactions among endoplasmic reticulum-associated degradation proteins. FEBS J 276: 1208-1220
20. Rumpf S, Jentsch S (2006) Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol Cell 21: 261-269
21. Schuberth C, Buchberger A (2008) UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell Mol Life Sci 65: 2360-2371
22. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6: 217-227
23. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE (2009) Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in yoblasts. Neuromuscul Disord 19: 766-772
24. Wang Q, Song C, Yang X, Li CC (2003) D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J Biol Chem 278: 32784-32793
25. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381
26. Weihl CC, Dalal S, Pestronk A, Hanson PI (2006) Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet 15: 189-199
27. Weihl CC, Pestronk A, Kimonis VE (2009) Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul Disord 19: 308-315
28. Yeung HO, Kloppsteck P, Niwa H, Isaacson RL, Matthews S, Zhang X
29. Freemont PS (2008) Insights into adaptor binding to the AAA protein p97. Biochem Soc Trans 36: 62-67
30. Zhang X et al (2000) Structure of the AAA ATPase p97. Mol Cell 6: 1473-1484